A subgroup analysis of the ODYSSEY APPRISE study: Safety and efficacy of alirocumab in the Italian cohort
- Autori: Cefalu', Angelo B; Garbelotto, Raffaella; Mombelli, Giuliana; Pirro, Matteo; Rubba, Paolo; Arca, Marcello; Borghi, Claudio; Bonomo, Katia; Gonnelli, Stefano; Massaroni, Katia; Tirone, Giampaolo; Averna, Maurizio
- Anno di pubblicazione: 2022
- Tipologia: Articolo in rivista
- OA Link: http://hdl.handle.net/10447/571067
Abstract
ODYSSEY APPRISE trial evaluated efficacy and safety of alirocumab in 994 patients with hypercholesterolemia and high CV risk in a real-life setting. The aim of the present report is to detail on the Italian cohort enrolled and treated in the trial.